Skip to main content

ADVERTISEMENT

Mahmood Razavi, MD

CLI Perspectives
12/06/2016
In this issue, I am honored at the chance to interview Dr. Mahmood Razavi, one of the pioneers in CTO crossing who has historically demonstrated that combining proper technical skill to a uniquely designed CTO device provides a favorable...
In this issue, I am honored at the chance to interview Dr. Mahmood Razavi, one of the pioneers in CTO crossing who has historically demonstrated that combining proper technical skill to a uniquely designed CTO device provides a favorable...
In this issue, I am honored at...
12/06/2016
Cath Lab Digest
Interview
01/03/2020
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the...
01/03/2020
Vascular Disease Management
Dr Mahmood Razavi
AMP 2023
11/02/2023
In this video, Dr. Mahmood Razavi discusses his presentation at AMP 2023 about patient follow-up after revascularization.
In this video, Dr. Mahmood Razavi discusses his presentation at AMP 2023 about patient follow-up after revascularization.
In this video, Dr. Mahmood...
11/02/2023
Vascular Disease Management
Interview
03/16/2023
Interventional Radiologist Mahmood K. Razavi, MD, FSIR, talks about results from the Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature (LAVA) study.
Interventional Radiologist Mahmood K. Razavi, MD, FSIR, talks about results from the Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature (LAVA) study.
Interventional Radiologist...
03/16/2023
Vascular Disease Management